ILI Pulse: A(H5N1) outbreaks in the USA
This free ILI Pulse report explores the most recent surveillance, information on vaccination, and evolution of avian influenza A(H5N1) outbreaks in the USA. Three recent
Read article
Category
Reports, Whitepapers & e-Books
ILI Pulse: What do we know about emerging SARS-CoV-2 variants and global COVID-19 activity?
In this free ILI Pulse report, we contextualize the evolving landscape of the SARS-CoV-2 virus since the Omicron variant’s emergence in late 2021. This emergence
Read article
2022–2023 global influenza activity analysis and commentary
Learn about how we use a data-driven approach to summarize notable influenza trends and activity globally for the current/upcoming season, and highlight regions that have
Read article
Revealing the Hidden Threat: Three innovative strategies for assessing disease burden today, tomorrow, and beyond
As the frequency, scale, and impact of infectious disease outbreaks continue to increase, the pharmaceutical industry faces significant challenges in assessing emerging needs and opportunities
Read article
The AI revolution in pharma
Learn how the pharma industry can reduce research and development (R&D) costs, create more efficient research operations, and manage the risks involved by leveraging AI.
Read article
How to build a resilient supply chain in the face of ongoing biothreats
Like cyberattacks, biothreats are shifting from “once in a lifetime” events to constant, costly disruptions that require active monitoring. Our latest guide, “How to Build
Read article
5 top biothreat risks to enterprises in 2022
Learn about the factors driving the ever-increasing risk of biothreats, five current biothreats that are top-of-mind for risk managers, and how to incorporate biothreat intelligence
Read article
How AI-powered biothreat intelligence improves pharma sales & supply chain performance
Learn about how to improve market research using high-resolution, geographically-granular infectious disease data, and strategies for enhancing market segmentation and sales-force targeting. Knowing where disease
Read article
An OSINT approach to event-based surveillance for epidemic intelligence
Discover ways in which BlueDot uses open source intelligence (OSINT) strategies and methodologies to supplement and strengthen epidemic intelligence. Open source intelligence (OSINT) is the
Read article
Mass gathering risk assessment framework
Access BlueDot’s framework for assessing risk from mass gathering events, using key examples from the risk assessments completed for the 2022 Hajj pilgrimage and 2020
Read article